{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-044154","form_type":"8-K","ticker":"APYX","cik":"0000719135","company_name":"Apyx Medical Corp","filed_at":"2024-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.899818+00:00","generated_at":"2026-05-30T03:07:13.294070+00:00","sec_items":["1.01","2.02","2.03","3.02","5.02","8.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Apyx Medical Q3 revenue down 4% to $11.5M; cuts FY24 guidance; workforce –25%","bullets":["Net loss $4.7M ($0.14/share) vs $4.6M YoY; adjusted EBITDA loss $2.4M.","Total revenue $11.5M (Advanced Energy -6% to $9.3M; OEM +3% to $2.2M).","FY24 revenue guidance cut to $46.6-47.6M from prior $50.6-52.1M; net loss expected ~$25M.","Raised ~$7M via registered direct offering of 3M shares + pre-funded warrants at $1.18/share.","Reduced U.S. workforce ~25% for ~$4.3M annual savings; three directors resigned; COO appointed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-044154","json":"https://secwatch.observer/filing/0001493152-24-044154.json","markdown":"https://secwatch.observer/filing/0001493152-24-044154.md","text":"https://secwatch.observer/filing/0001493152-24-044154.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/719135/000149315224044154/0001493152-24-044154-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/719135/000149315224044154/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:07:13.294070+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a1836345f2","claim":"Michael Geraghty resigned as Director at Apyx Medical Corp.","evidence_excerpt":"On November 4, 2024, John Andres, Michael Geraghty, and Craig Swandal resigned from the Board of Directors, with such resignations effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/719135/000149315224044154/0001493152-24-044154-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ef8a401ff9","claim":"John Andres resigned as Director at Apyx Medical Corp.","evidence_excerpt":"On November 4, 2024, John Andres, Michael Geraghty, and Craig Swandal resigned from the Board of Directors, with such resignations effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/719135/000149315224044154/0001493152-24-044154-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"f435e0e377","claim":"Shawn D. Roman was appointed as Chief Operating Officer at Apyx Medical Corp.","evidence_excerpt":"On November 6, 2024, the Board appointed Shawn D. Roman as the Chief Operating Officer of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/719135/000149315224044154/0001493152-24-044154-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"f48f6fabe0","claim":"Craig Swandal resigned as Director at Apyx Medical Corp.","evidence_excerpt":"On November 4, 2024, John Andres, Michael Geraghty, and Craig Swandal resigned from the Board of Directors, with such resignations effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/719135/000149315224044154/0001493152-24-044154-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}